New guide issued for low back pain treatment
Low back pain guidelines are released from the American Pain Society and American College of Physicians
Published this week in the Annals of Internal Medicine are new guidelines for treating low back pain from the American Pain Society (APS) and the American College of Physicians. For drug treatment, the clinical practice guideline emphasizes that the pain medication chosen should have proven benefits and be appropriate for the severity of baseline pain and functional impairment. Special attention should also be given to the risks and benefits of each medication as well as long-term efficacy and safety data before initiating therapy. The new guidelines consist of seven recommendations that were unanimously approved by 25 members of the guideline panel. According to APS, low back pain is the fifth most common reason for physician office visits.
Click here to see more articles from Drug Topics Daily News.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
